Portfolio company
Third Wave Molecular Diagnostics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops molecular diagnostic reagents for DNA and RNA analysis applications for clinical laboratories, pharmaceutical companies, and academic research centres.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Molecular Designs
The company develops and manufactures multiplex PCR assays and nucleic acid extraction systems for clinical laboratories and research institutions.
NeuMoDx Molecular
The company develops automated molecular diagnostic systems and reagents for nucleic acid testing in clinical and hospital laboratories.
epoch-biosciences
This company develops genetic analysis tools and reagents for life science entities and molecular diagnostic researchers.
Diana Biotechnologies
This company develops PCR diagnostic kits and molecular biology reagents for healthcare providers, pharmaceutical partners and academic laboratories.
DENCODA
This biotechnology company develops DNA-linked probes and diagnostic assays for researchers and healthcare providers to detect disease biomarkers and enzyme activities.
QuantaLife
This company develops digital polymerase chain reaction systems for laboratories to identify and quantify DNA molecules for genetic analysis and disease diagnosis.
4BASES
This company develops diagnostic genetic testing kits and sequencing reagents for healthcare professionals and clinical laboratories to support precision medicine and disease prevention.
AgenDx Biosciences
This company develops a molecular diagnostics platform to provide cost-effective cancer and infectious disease testing for clinical settings and healthcare providers.
